Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

BRAF‐V600E expression correlates with ameloblastoma aggressiveness
Eduardo Rodrigues Fregnani, Danyel Elias da Cruz Pérez, Oslei Paes de Almeida, et al.
Histopathology (2016) Vol. 70, Iss. 3, pp. 473-484
Closed Access | Times Cited: 77

Showing 1-25 of 77 citing articles:

Ameloblastoma: current etiopathological concepts and management
OA Effiom, O M Ogundana, Abdulwarith Akinshipo, et al.
Oral Diseases (2017) Vol. 24, Iss. 3, pp. 307-316
Open Access | Times Cited: 261
Clinicopathological and Immunohistochemical Risk Predictors for Ameloblastoma Recurrence
Hévila de Figueiredo Pires, Glória Maria de França, Hannah Gil de Farias Morais, et al.
Head and Neck Pathology (2025) Vol. 19, Iss. 1
Closed Access | Times Cited: 1
Clinical benefit and radiological response with BRAF inhibitor in a patient with recurrent ameloblastoma harboring V600E mutation
Gustavo dos Santos Fernandes, Daniel M. Girardi, João Paulo Giacomini Bernardes, et al.
BMC Cancer (2018) Vol. 18, Iss. 1
Open Access | Times Cited: 69
The Molecular Pathology of Odontogenic Tumors: Expanding the Spectrum of MAPK Pathway Driven Tumors
Letícia Martins Guimarães, Bruna Pizziolo Coura, Ricardo Santiago Gomez, et al.
Frontiers in Oral Health (2021) Vol. 2
Open Access | Times Cited: 45
Advancements in MAPK signaling pathways and MAPK‐targeted therapies for ameloblastoma: A review
Zhu You, Shao‐Peng Liu, Jing Du, et al.
Journal of Oral Pathology and Medicine (2018) Vol. 48, Iss. 3, pp. 201-205
Closed Access | Times Cited: 50
Current concepts in ameloblastoma-targeted therapies in B-raf proto-oncogene serine/threonine kinase V600E mutation: Systematic review
Rogelio Gónzalez‐Gónzalez, Sandra López‐Verdín, Jesús Lavalle‐Carrasco, et al.
World Journal of Clinical Oncology (2019) Vol. 11, Iss. 1, pp. 31-42
Open Access | Times Cited: 48
Molecular biological findings of ameloblastoma
Takao Fuchigami, Yusuke Ono, Shosei Kishida, et al.
Japanese Dental Science Review (2021) Vol. 57, pp. 27-32
Open Access | Times Cited: 33
Study on clinical and biological characteristics of ameloblastic carcinoma
Zhixing Niu, Ye Li, Wantao Chen, et al.
Orphanet Journal of Rare Diseases (2020) Vol. 15, Iss. 1
Open Access | Times Cited: 35
High prevalence of BRAF V600E mutations in Korean patients with ameloblastoma: Clinicopathological significance and correlation with epithelial‐mesenchymal transition
Kyu‐Young Oh, Sung‐Dae Cho, Hye‐Jung Yoon, et al.
Journal of Oral Pathology and Medicine (2019) Vol. 48, Iss. 5, pp. 413-420
Closed Access | Times Cited: 34
Downregulated miR-524-5p Participates in the Tumor Microenvironment of Ameloblastoma by Targeting the Interleukin-33 (IL-33)/Suppression of Tumorigenicity 2 (ST2) Axis
Lijie Chen, Guannan Wang, Xue Qiao, et al.
Medical Science Monitor (2020) Vol. 26
Open Access | Times Cited: 29
BRAF V600E Mutation in Ameloblastoma: A Systematic Review and Meta-Analysis
Mohd Nazzary Mamat Yusof, Ewe Seng Ch’ng, Nawal Radhiah Abdul Rahman
Cancers (2022) Vol. 14, Iss. 22, pp. 5593-5593
Open Access | Times Cited: 16
Immunohistochemical analysis of BRAF V600E mutation in ameloblastomas
Alan Motta do Canto, Barbara Michaela Reis da Silva Marcelino, Juliana Lucena Schussel, et al.
Clinical Oral Investigations (2018) Vol. 23, Iss. 2, pp. 779-784
Closed Access | Times Cited: 30
WHO is in and WHO is out of the mouth, salivary glands, and jaws sections of the 4th edition of the WHO classification of head and neck tumours
Robert Kennedy
British Journal of Oral and Maxillofacial Surgery (2018) Vol. 56, Iss. 2, pp. 90-95
Open Access | Times Cited: 28
The diagnostic utility of BRAF VE1 mutation-specific immunohistochemistry in ameloblastoma
Luvy Delfin Mendez, Nicholas S. Wolsefer, L. Sylvia, et al.
Modern Pathology (2022) Vol. 35, Iss. 11, pp. 1570-1577
Open Access | Times Cited: 15
Analysis of BRAF V600E expression and disease-free survival in patients with ameloblastoma
Sumana Kunmongkolwut, Risa Chaisuparat
International Journal of Oral and Maxillofacial Surgery (2022) Vol. 51, Iss. 8, pp. 1034-1042
Closed Access | Times Cited: 14
Does BRAF V600E mutation affect recurrence rate of ameloblastomas? Systematic review and meta‐analysis
Allan Vinícius Martins‐de‐Barros, Caio César Gonçalves Silva, Kalyne Kelly Negromonte Gonçalves, et al.
Journal of Oral Pathology and Medicine (2023) Vol. 52, Iss. 8, pp. 701-709
Closed Access | Times Cited: 8
COX-2 as a determinant of lower disease-free survival for patients affected by ameloblastoma
Marco Aurélio Petroni Montezuma, Felipe Paiva Fonseca, Bernar Monteiro Benites, et al.
Pathology - Research and Practice (2018) Vol. 214, Iss. 6, pp. 907-913
Closed Access | Times Cited: 24
An immunohistochemical and genetic study of BRAFV600E mutation in Japanese patients with ameloblastoma
Mai Seki, Takaaki Sano, Kenta Ito, et al.
Pathology International (2020) Vol. 70, Iss. 4, pp. 224-230
Closed Access | Times Cited: 23
<p>A Novel lncRNA ENST00000512916 Facilitates Cell Proliferation, Migration and Cell Cycle Progression in Ameloblastoma</p>
Yan Sun, Xing Niu, Guannan Wang, et al.
OncoTargets and Therapy (2020) Vol. Volume 13, pp. 1519-1531
Open Access | Times Cited: 22
Factors Associated with Recurrence of Ameloblastoma: A Scoping Review
Pornnutcha Inthong, Witsarut Upalananda, Jirayu Saepoo
Head and Neck Pathology (2024) Vol. 18, Iss. 1
Closed Access | Times Cited: 2
Low frequency of BRAF V600E immunoexpression in mandibular ameloblastomas: An institutional study
RajivS Desai, PankajM Shirsat, Shivani Bansal, et al.
Journal of Oral and Maxillofacial Pathology (2018) Vol. 22, Iss. 3, pp. 353-353
Open Access | Times Cited: 23
High frequency of BRAF V600E mutation in Iranian population ameloblastomas
Samira Derakhshan, Pouyan Aminishakib, Abbas Karimi, et al.
Medicina oral, patología oral y cirugía bucal (2020), pp. e502-e507
Open Access | Times Cited: 19
Comparison of Immunohistochemistry and DNA Sequencing for BRAF V600E Mutation Detection in Mandibular Ameloblastomas
Barbara Michaela Reis da Silva Marcelino, Guilherme Klein Parise, Alan Motta do Canto, et al.
Applied immunohistochemistry & molecular morphology (2021) Vol. 29, Iss. 5, pp. 390-393
Closed Access | Times Cited: 16
Identification of BRAF V600E mutation in odontogenic tumors by high-performance MALDI-TOF analysis
Lucrezia Togni, Antonio Zizzi, Roberta Mazzucchelli, et al.
International Journal of Oral Science (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 11
Resolution of PTHrP-Mediated Hypercalcemia Following Treatment with Dual BRAF/MEK Inhibition for BRAFV600E-Positive Metastatic Ameloblastoma
Kathryn Corbett, Dean Ruether, Isolde Seiden‐Long, et al.
Calcified Tissue International (2024) Vol. 114, Iss. 4, pp. 444-449
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top